Pancreatic Cancer Story: James Dadge
James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...
Meningitis progress lags behind other vaccinated diseases
Meningitis progress lags substantially behind that of other vaccine preventable diseases, according to new research The global disease burden of meningitis remains unacceptably high, and...
Government grant for research into new class of antibiotic
A new class of antibiotic hailed as the 'last line of defence' in the battle against drug-resistant superbugs such as MSRA and VRE is...
Study shows potential to develop brain tumour liquid biopsies
Scientists are making strides in developing brain tumour liquid biopsies by detecting tumour DNA in the fluid from around the brain and spine. Liquid biopsies...
Should an NHS cash boost be used to cut waiting times?
New polling has found that the majority of the public want the promised NHS cash boost to be used to help cut record high...
Medicinal cannabis now available on prescription
As of today, expert doctors can legally issue prescriptions for cannabis-based products for medicinal use. Prescribing decisions for medicinal cannabis are restricted to clinicians...
Social media project results in 13% more breast screenings
An NHS project using social media to improve health by boosting digital inclusion has led to a 13 per cent increase in first time...
Commons Select Committee calls for clinical trials transparency
The Science and Technology Committee has expressed concern that nearly half of clinical trials fail to publish their results. The Committee is calling for...
Kate Lancaster will be the new RCOG Chief Executive
Kate Lancaster, the Director of Strategy at East and North Hertfordshire NHS Trust will be the new RCOG Chief Executive. The Royal College of Obstetricians...
Annual report on GP activity in England
NHS Digital has published its annual report on GP activity in England. It shows the prevalence of 21 conditions and identifies how the prevalence...
Latest articles
IMBRUVICA® misses primary endpoint in pancreatic cancer trial
AbbVie have released an update on the RESOLVE trial of IMBRUVICA® in combination with chemotherapy agents in metastatic pancreatic cancer. AbbVie, a research-based global biopharmaceutical company,...
Star Europe’s Amsterdam office off to positive start
Star Europe has reported good feedback in the Netherlands since opening its Amsterdam office in November. Supported by established resources and infrastructure, the team at...
EC approves Vertex’s ORKAMBI® for cystic fibrosis patients
Vertex Pharmaceuticals announces that the European Commission has granted approval of the label extension for ORKAMBI® for cystic fibrosis patients. The European Commission has granted approval...